Latest Blogs

Sai's picture

Purdue admits lies over Oxycontin risks

Submitted by Sai on Fri, 05/11/2007 - 17:36
0
Your rating: None

Purdue has now acknowledged that it illegally promoted OxyContin by falsely claiming that it was "less addictive, less subject to abuse and diversion, and less likely to cause withdrawal symptoms than other pain medications - all in an effort to maximise its profits" .

Sailaja Byrisetty's picture

New 'cold sore prevention system’ in Canada called “Intercept CS”

Submitted by Sailaja Byrisetty on Sat, 05/05/2007 - 17:28
0
Your rating: None

It is a medical device approved for the PREVENTION of cold sores. Manufacturer says that this product works by sending a ‘heat shock' to the area where the cold sore is expected to develop. It seems Intercept CS produces ‘heat shock proteins' in the skin which might kill virally-infected cells. It is a medical device approved for the PREVENTION of cold sores.

ajaypalsingh's picture

Cancer vaccines on the horizon

Submitted by on Sat, 05/05/2007 - 12:01
0
Your rating: None

On 29 March this year, the US FDA's Office of Cellular, Tissue and Gene Therapies Advisory Committee met to discuss the fate of Dendreon's leading cancer vaccine candidate Provenge (Sipuleucel-T). Provenge represents an extreme of 'personalized medicine'. Dendritic cells, which mop up antigens and present them to other cells of the immune system to stimulate a response, are taken from patients and then sent to one of Dendreon's repositories where they are treated with the prostate-specific antigen prostatic acid phosphatase (PAP), which is found in 95% of prostate cancers.

ajaypalsingh's picture

Methods for inhibiting viral replication in vivo

Submitted by on Fri, 05/04/2007 - 11:52
0
Your rating: None

 

Sai's picture

Pfizer Wins against Novopharm on Celebrex Patent Decision in Canadian Court

Submitted by Sai on Thu, 05/03/2007 - 17:06
0
Your rating: None

 The Federal Court of Appeal of Canada in Toronto has blocked Teva's Novopharm  to launch its form of Celebrex in Canada according to Pfizer statement on May 1st  .

This ruling will prevent Teva Pharmaceutical Industries Ltd. from launching a copycat form of its Celebrex arthritis drug in the country until 2014.

ajaypalsingh's picture

GDEPT: ISSUES AND STRATEGIES

Submitted by on Thu, 05/03/2007 - 12:23
0
Your rating: None

 

The bystander cytotoxic effect, defined as the extension of the killing effects of an activated prodrug produced locally within a tumor to surrounding tumor cells, is a key feature of gene-directed enzyme prodrug therapy (GDEPT) for cancer, given that the limitation of current technologies for gene delivery allows for only a small percentage of tumor cells to be transduced with a therapeutic gene.

ajaypalsingh's picture

Polymer-directed enzyme prodrug therapy

Submitted by on Thu, 05/03/2007 - 12:16
0
Your rating: None

 

I read this information  from a research paper

ajaypalsingh's picture

Nanocapsules may improve TB treatment

Submitted by on Mon, 04/30/2007 - 12:49
0
Your rating: None

this is the breaking news of one scientific news channel 

ajaypalsingh's picture

Chrono Therapeutics makes efficient drug delivery

Submitted by on Fri, 04/27/2007 - 15:54
0
Your rating: None

  i have read this information from one of the patent

Chrono Therapeutics has unveiled a wristwatch-like device for the non-invasive automatic administration of drugs based on the amount and time instructed, thus improvingpatience compliance.

 

Chrono Dose is programmed like an alarm clock and worn like a watch to accurately deliver predefined-sized doses to coincide with peak disease symptoms.

Sailaja Byrisetty's picture

Glitazones increasing fractures:

Submitted by Sailaja Byrisetty on Mon, 04/23/2007 - 04:52
0
Your rating: None

I read this article from one of the pharmacy news letter.

There is concern about fractures in women using AVANDIA (rosiglitazone) and ACTOS (pioglitazone).  Health Canada is warning about use of these medications.  Women, whoever is using these drugs, seem to get more fractures of the arm, hand, ankle, and foot...but not hip or spine so far.  Similar risk is not found in men it seems. Health Canada is recommending to tell women that this doesn't prove that glitazones cause fractures, but suggest monitoring bone density in women who are at risk for fractures or falls.